Simulations Plus entered into a definitive merger agreement to be acquired by affiliates of Altaris, LLC, a prominent healthcare-focused private investment firm. Under the terms of the transaction agreement, Altaris agreed to take the company private through an all-cash acquisition valued at approximately $375 million, offering stockholders $18.50 per share in cash. Upon the final completion of the transaction, Simulations Plus is set to be combined with Chemical Computing Group (CCG), which is an existing portfolio company under Altaris that specializes in advanced molecular design software. The transaction involves transitioning Simulations Plus into a privately held subsidiary, meaning its common stock will be delisted from the Nasdaq Stock Exchange once all regulatory clearances and customary closing conditions are fully satisfied.